← Back to Patent Explorer
EP0068660A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Protection against dental caries

Assignee: UK Secretary of State for Social Services
•
Filing: 1982-06-04
•
Granted: —
•
Expires: 2002-06-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An antigenic protein, termed antigen C, present on the cell walls and in cultures of Streptococcus mutans, especially genetic group I (serotypes c, e and f) is separated from other antigenic proteins, notably those which cross react with heart tissue, to give an antigen preparation which may be used as a vaccine or to raise antibodies for use in protecting against dental caries. <??>Antigen C is destroyed or extracted from the cell walls by treatment with boiling aqueous sodium dodecyl sulphate (10 gm per litre) for 10 minutes. It has a molecular weight of 70,000 +/- 5,000 and an isoelectric point of 4.45 +/- 0.24. It is destroyed by proteolytic enzyme and does not cross react with heart tissue. <??>The antigen also occurs in the culture filtrate and/or cell extract and may readily be separated from these sources by affinity chromatography on immobilised antibody.

Inventors

  • 👤 Roy Robert Baird Russell

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-08 08:51
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/64; A61K39/00; A61K39/02; A61K39/09; A61K39/092; A61K8/96; A61K8/99; A61Q; A61Q11/00; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822; Y10S435/885; Y10S530/00; Y10S530/806; Y10S530/808; Y10S530/809; Y10S530/81; Y10S530/82; Y10S530/825

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 31 words
An antigen preparation for use in the reduction or prevention of dental caries comprising antigen C, said preparation being substantially free from any heart cross reactive antigens derivable from Streptococcus mutans.
Claim 2
Dependent Claim 31 words
An antigen preparation for use in the reduction or prevention of dental caries comprising antigen C, said preparation being substantially free from any heart cross reactive antigens derivable from Streptococcus mutans.
Claim 3
Dependent Claim 17 words
An antigen preparation according to claim 1 derived from a strain of Streptococcus mutans genetic group I.
Claim 4
Dependent Claim 16 words
An antigen preparation according to claim 2 derived from a strain of Streptococcus mutans serotype c.
Claim 5
Dependent Claim 18 words
An antigen preparation according to any one of claims 1 to 3 comprising antigen C and antigen A.
Claim 6
Dependent Claim 49 words
A pharmaceutical preparation for use in the reduction or prevention of dental caries comprising an active component in conjunction with a pharmaceutically acceptable diluent or carrier characterised in that the active component is either an antigen preparation according to any one of claims 1 to 4 or antibodies thereto.
Claim 7
Dependent Claim 16 words
A pharmaceutical preparation according to claim 5 in a form suitable for injection or oral administration.
Claim 8
Dependent Claim 27 words
A pharmaceutical preparation according to claim 5 in a form suitable for topical application to the mouth, especially in the form of a toothpaste or a mouthwash.
Claim 9
Dependent Claim 84 words
L. A process for producing an antigen preparation according to any one of claims 1 to 4 comprising growing bacteria of the species Streptococcus mutans in a suitable culture medium, removing at least the cell walls from the resulting culture to leave a protein solution and separating the required antigen preparation from said protein solution characterised in that the antigen preparation is separated from the protein solution by a method of separation including the step of affinity chromatography on immobilised antibody to antigen C.
Claim 10
Dependent Claim 82 words
A process for producing an antigen preparation according to claim 4 comprising growing bacteria of the species Streptococcus mutans in a suitable culture medium, removing at least the cell walls from the resulting culture to leave a protein solution and separating the required antigen preparation from said protein solution characterised in that the antigen preparation is separated from the protein solution by a method of separation including the step of affinity chromatography on immobilised antibody to both antigen C and antigen A.
Claim 11
Dependent Claim 35 words
A process according to either claim 8 or claim 9 characterised in that the bacteria are grown at a dilution rate of between 0.01 and 0.1 hr - 1 , especially about 0.05 hr -1.

References Cited (Backward Citations)

GB1375866A Cited
US4150116A Cited
GB2033223A Cited
GB2060647A Cited
US4250262A Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag